1.Therapy of Pancreatic Neuroendocrine Tumors: Fine Needle Intervention including Ethanol and Radiofrequency Ablation.
Clinical Endoscopy 2017;50(6):546-551
Pancreatic neuroendocrine tumors (PNETs) are increasingly being detected, though usually as incidental findings. Majority of the PNETs are non-functional and surgical resection is the standard of care for most of them. However, in patients with small PNETs localized within the pancreas, who are unfit or unwilling for surgery, alternate methods of treatment are needed. Direct methods of ablation of PNETs, using either ethanol injection or radiofrequency ablation (RFA), are emerging as effective methods. The limited literature available as case reports or case series on endoscopic ultrasound (EUS)-guided local ablation using either ethanol or RFA has demonstrated safety and efficacy along with short- to medium-term sustained relief. Long-term benefits with these local ablative therapies are awaited. Comparative studies are needed to show which of these two competing technologies is superior. Finally, comparative trials of EUS-guided ablation with surgical resection in terms of efficacy and safety will ensure their place in the management algorithm.
Catheter Ablation*
;
Ethanol*
;
Humans
;
Incidental Findings
;
Needles*
;
Neuroectodermal Tumors, Primitive
;
Neuroendocrine Tumors*
;
Pancreas
;
Standard of Care
;
Ultrasonography
2.Diagnosis of Pancreatic Neuroendocrine Tumors.
Dong Wook LEE ; Michelle Kang KIM ; Ho Gak KIM
Clinical Endoscopy 2017;50(6):537-545
Pancreatic neuroendocrine tumors (PNETs) are relatively rare; however, the incidence has increased over the last few decades. They are classified as functional or non-functional tumors according to the presence of associated clinical symptoms. The majority are non-functional tumors. For classification and staging, the World Health Organization 2010 classification system is the most commonly accepted. Chromogranin A is the most sensitive marker but has insufficient specificity. In general, PNETs are hypervascular tumors, and multiphasic contrast-enhanced computed tomography is considered the first choice for imaging study. Multiphasic magnetic resonance imaging can detect PNETs smaller than 2 cm and small liver metastasis compared with other modalities. Somatostatin receptor scintigraphy is often used in cases where functional PNETs are suspected. Positron emission tomography (PET) scan with 18F-fluorodeoxyglucose cannot visualize PNETs, but PET with 68-Ga DOTATATE can. Endoscopic ultrasonography can characterize smaller PNETs using contrast and confirm histology through fine needle aspiration or biopsy. In this article, we review the characteristics of grading systems and diagnostic modalities commonly used for PNETs.
Biopsy
;
Biopsy, Fine-Needle
;
Chromogranin A
;
Classification
;
Diagnosis*
;
Endosonography
;
Incidence
;
Liver
;
Magnetic Resonance Imaging
;
Neoplasm Metastasis
;
Neuroectodermal Tumors, Primitive
;
Neuroendocrine Tumors*
;
Positron-Emission Tomography
;
Radionuclide Imaging
;
Receptors, Somatostatin
;
Sensitivity and Specificity
;
World Health Organization
3.Diagnosis and Management of Rectal Neuroendocrine Tumors.
Shreya CHABLANEY ; Zachary A ZATOR ; Nikhil A KUMTA
Clinical Endoscopy 2017;50(6):530-536
The incidence of rectal neuroendocrine tumors (NETs) has increased by almost ten-fold over the past 30 years. There has been a heightened awareness of the malignant potential of rectal NETs. Fortunately, many rectal NETs are discovered at earlier stages due to colon cancer screening programs. Endoscopic ultrasound is useful in assessing both residual tumor burden after retrospective diagnosis and tumor characteristics to help guide subsequent management. Current guidelines suggest endoscopic resection of rectal NETs ≤10 mm as a safe therapeutic option given their low risk of metastasis. Although a number of endoscopic interventions exist, the best technique for resection has not been identified. Endoscopic submucosal dissection (ESD) has high complete and en-bloc resection rates, but also an increased risk of complications including perforation. In addition, ESD is only performed at tertiary centers by experienced advanced endoscopists. Endoscopic mucosal resection has been shown to have variable complete resection rates, but modifications to the technique such as the addition of band ligation have improved outcomes. Prospective studies are needed to further compare the available endoscopic interventions, and to elucidate the most appropriate course of management of rectal NETs.
Colonic Neoplasms
;
Diagnosis*
;
Incidence
;
Ligation
;
Mass Screening
;
Neoplasm Metastasis
;
Neoplasm, Residual
;
Neuroendocrine Tumors*
;
Prospective Studies
;
Retrospective Studies
;
Ultrasonography
4.Diagnosis and Management of Upper Gastrointestinal Neuroendocrine Tumors.
Jun Liong CHIN ; Dermot O'TOOLE
Clinical Endoscopy 2017;50(6):520-529
Upper gastrointestinal neuroendocrine tumors (NETs) are rare tumors which are increasingly recognised by practising endoscopists. After confirmation by endoscopic biopsies of these focal lesions, many questions may arise. As NETs are less frequently encountered compared to other malignancies or gastrointestinal pathology, many endoscopists may not fully understand the natural history, diagnosis and management of these tumors. In this review, we aim to update the practising endoscopist on the key clinical features and management of patients with upper gastrointestinal NET.
Biopsy
;
Diagnosis*
;
Humans
;
Natural History
;
Neuroendocrine Tumors*
;
Pathology
5.Can Endoscopic Ultrasonography Prevent Unnecessary Endoscopic Retrograde Cholangiopancreatography in Patients with High and Intermediate Likelihood of Choledocholithiasis?.
Clinical Endoscopy 2017;50(6):518-519
No abstract available.
Cholangiopancreatography, Endoscopic Retrograde*
;
Choledocholithiasis*
;
Endosonography*
;
Humans
6.Proper Treatment Option for Small Rectal Neuroendocrine Tumors Using Precut Endoscopic Mucosal Resection.
Clinical Endoscopy 2017;50(6):516-517
No abstract available.
Neuroendocrine Tumors*
7.Clinical Significance of Risk Factors for Asymptomatic Peptic Ulcer Disease.
Cheal Wung HUH ; Byung Wook KIM
Clinical Endoscopy 2017;50(6):514-515
No abstract available.
Peptic Ulcer*
;
Risk Factors*
8.Endoscopic Resection of Early Gastric Cancer with Undifferentiated-Type Histology.
Clinical Endoscopy 2017;50(6):511-513
No abstract available.
Stomach Neoplasms*
9.Image-Enhanced Endoscopy for Diagnosis and Treatment of Gastrointestinal Tumor.
Clinical Endoscopy 2013;46(4):423-424
No abstract available.
Endoscopy
10.Retroperitoneal Cystic Lymphangioma Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Aspiration.
Tyler BLACK ; Cynthia D GUY ; Rebecca A BURBRIDGE
Clinical Endoscopy 2013;46(5):595-597
Retroperitoneal cystic lymphangiomas are rare tumors of the lymphatic system. These tumors usually present in childhood and are often diagnosed incidentally with imaging procedures. Although benign, they can grow to large sizes and become symptomatic due to their compressive effects. They can cause diagnostic dilemmas with other retroperitoneal cystic tumors including those arising from the liver, kidney, and pancreas. Endoscopic ultrasound (EUS) has become an invaluable tool in the assessment of cystic lesions in the region of the pancreas. This case describes a 66-year-old female who presented with 3 months of abdominal pain. Radiographic imaging was suggestive of a cystic lesion in the region of the pancreas. EUS was performed confirming a cystic lesion adjacent to the tail of the pancreas with subsequent fine needle aspiration fluid analysis consistent with a cystic lymphangioma.
Abdominal Pain
;
Aged
;
Biopsy, Fine-Needle
;
Endoscopic Ultrasound-Guided Fine Needle Aspiration
;
Endosonography
;
Female
;
Humans
;
Kidney
;
Liver
;
Lymphangioma
;
Lymphangioma, Cystic
;
Lymphatic System
;
Pancreas
;
Retroperitoneal Neoplasms